Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period
Aim. To study markers that determine residual platelet reactivity in the subacute period of myocardial infarction (MI) during the administration of acetylsalicylic acid (ASA) as part of dual antiplatelet therapy.Material and methods. 405 patients with MI (79.5% men and 20.5% women, average age 58.0...
Saved in:
| Main Authors: | T. P. Pronko, V. A. Snezhitskiy, A. V. Kapytski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2025-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/3037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01) -
Antiplatelet therapy – platelet function test for platelet response assessment
by: D. Dineva, et al.
Published: (2025-05-01) -
Platelet phenotypes and practical aspects of platelet function testing in cardiology
by: Zh. D. Kobalava, et al.
Published: (2023-12-01) -
EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01) -
The impact of platelets and antiplatelets medications on immune mediation
by: Leela Morena, MD, et al.
Published: (2025-01-01)